XML 70 R61.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Shares        
Outstanding Beginning Balance (in shares) 217,519   217,519  
Exercised (in shares) 0 (2,481) 0 (4,481)
Outstanding Ending Balance (in shares) 217,519   217,519  
Exercisable at end of period (in shares) 217,519   217,519  
Weighted-Average Exercise Price        
Outstanding Beginning Balance (in dollars per share) $ 11.20   $ 11.20  
Exercised (in dollars per share) 0   0  
Outstanding Ending Balance (in dollars per share) $ 11.20   $ 11.20  
Exercisable at end of period, Weighted Average Exercise Price (in dollars per share) 11.20   11.20  
Weighted-Average Remaining Contractual Term in Years        
Outstanding Ending Balance (in years) 11 months 8 days   11 months 8 days  
Exercisable at end of period, Weighted Average Remaining Contractual Term in Years 11 months 8 days   11 months 8 days  
Aggregate Intrinsic Value        
Outstanding Beginning Balance $ 353,111   $ 823,028  
Exercised   0  
Outstanding Ending Balance 104,584   104,584  
Exercisable at end of period, Aggregate Intrinsic Value $ 104,584   $ 104,584  
Share Based Compensation, Stock Option Plan, Additional Disclosures [Abstract]        
Nonvested Beginning Balance, Weighted-Average Grant Date Fair Value (in dollars per share) $ 4.10   $ 4.10  
Exercised, Weighted Average Grant Date Fair Value (in dollars per share)   0  
Nonvested Endingg Balance, Weighted-Average Grant Date Fair Value (in dollars per share) 4.10   4.10  
Exercisable at end of period, Weighted Average Grant Date Fair Value (in dollars per share) $ 4.10   $ 4.10  
Vested        
Shares        
Expected to Vest (in shares) 217,519   217,519  
Weighted-Average Exercise Price        
Expected to Vest, Weighted Average Exercise Price (in dollars per share) $ 11.20   $ 11.20  
Weighted-Average Remaining Contractual Term in Years        
Expected to Vest, Weighted Average Remaining Contractual Term in Years 11 months 8 days   11 months 8 days  
Aggregate Intrinsic Value        
Expected to Vest, Aggregate Intrinsic Value $ 104,584   $ 104,584  
Share Based Compensation, Stock Option Plan, Additional Disclosures [Abstract]        
Expected to Vested, Weighted Average Grant Date Fair Value (in dollars per share) $ 4.10   $ 4.10